Powered by

Medtronic Initiates Pivotal Trial for Bluetooth Enabled MiniMed(TM) 780G Advanced Hybrid Closed Loop System Designed to Automate Correction Bolusing

Jun 08, 2019 - Thomson Reuters ONE

DUBLIN - June 8, 2019 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced the enrollment of the first study participants in the company's pivotal trial of its Bluetooth(R) enabled MiniMed(TM) 780G advanced hybrid closed loop (AHCL) system. This next-generation system is designed to automate the delivery of correction boluses when the user experiences, or is predicted to experience, prolonged high glucose levels based on their sensor readings. The trial will evalu...